Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 7/20 | 0.45 |
| ▸ | MMP13 | P45452 | 3/20 | 0.45 |
| ▸ | MMP2 | P08253 | 7/20 | 0.43 |
| ▸ | MMP3 | P08254 | 7/20 | 0.43 |
| ▸ | MMP7 | P09237 | 5/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | MMP8 | P22894 | 3/20 | 0.41 |
| ▸ | GCK | P35557 | 2/20 | 0.41 |
| ▸ | MMP9 | P14780 | 2/20 | 0.41 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.40 |
| ▸ | MMP12 | P39900 | 1/20 | 0.40 |
| ▸ | MMP14 | P50281 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7849158 | 1.00 | MMP1 (0.45) | MMP1MMP13MMP2MMP3MMP7 | |
| SCHEMBL7847144 | 0.90 | MMP1 (0.43) | MMP1MMP13MMP2MMP3MMP7 | |
| SCHEMBL7847147 | 0.90 | MMP1 (0.43) | MMP1MMP13MMP2MMP3MMP7 | |
| SCHEMBL7844907 | 0.89 | L3MBTL1 (0.43) | MMP1MMP13MMP2MMP3MMP7 | |
| SCHEMBL7844905 | 0.89 | L3MBTL1 (0.43) | MMP1MMP13MMP2MMP3MMP7 | |
| SCHEMBL7846699 | 0.88 | MMP1 (0.43) | MMP1MMP13MMP2MMP3MMP7 | |
| SCHEMBL7846703 | 0.88 | MMP1 (0.43) | MMP1MMP13MMP2MMP3MMP7 | |
| SCHEMBL7849870 | 0.88 | HPGD (0.51) | MMP1MMP13MMP2MMP3MMP7 | |
| SCHEMBL7849871 | 0.88 | HPGD (0.51) | MMP1MMP13MMP2MMP3MMP7 | |
| SCHEMBL7845190 | 0.87 | L3MBTL1 (0.41) | MMP1MMP3L3MBTL1SMN1; SMN2GCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1137640-A1 | CYCLIC HYDRAZINE DERIVATIVES AS TNF-ALPHA INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2001-10-04 | — | — | EP | disclosed |
| US-6281363-B1 | ANTIINFLAMMATORY AGENTS; ANTIARTHRITIC AGENTS; AUTOIMMUNE DISORDERS | HOFFMANN-LA ROCHE INC. | 2001-08-28 | — | — | US | disclosed |
| WO-2000035885-A1 | CYCLIC HYDRAZINE DERIVATIVES AS TNF-ALPHA INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2000-06-22 | — | — | WO | disclosed |